MedTech Insights

Volume XIX, Issue 1 | January 5, 2017 | By: Clay Heskett, Helen Chen, Peter Rosenorn, David Barrow

Developing therapeutics and medical devices for global healthcare markets remains a risky proposition. The medical innovations now coming to market are remarkable and reflect the reaction of healthcare companies towards innovation a decade ago. Globally, the biopharma and medtech sectors are being shaped by four significant forces, which will determine the success factors for the next generation of healthcare products. In this Executive Insights, L.E.K. examines each of the key forces driving change.

Volume XVIII, Issue 46 | December 2, 2016 | By: Kevin Grabenstatter, Wiley Bell

What will the transition to a Trump administration mean for the healthcare industry’s key constituents? While experts of all stripes are asserting predictions, they are typically long on speculation and short on evidence. In a moment of political uncertainty, it is most useful to know which issues and stakeholder “tensions” to watch closely. This Executive Insights will highlight some of these questions.

Analysis | December 1, 2016 | By: Jonas Funk, Lucas Pain

The 2016 Strategic Hospital Priorities Study examines the current direction of the industry and, in particular, how Medtech companies can capitalize on the many needs of hospital administrators.

Volume XVIII, Issue 33 | October 7, 2016 | By: Jonas Funk, Stuart Jackson, Lucas Pain

Hospital systems are increasingly open to a broader range of services and affiliated solutions in an effort to streamline patient care, improve outcomes and treat illnesses more effectively. This Executive Insights identifies five key success factors that will help medtechs provide truly effective, wide-ranging solutions without losing their competitive edge.

Volume XVIII, Issue 30 | August 9, 2016 | By: Peter Smith

There are only a few KPIs which have a large influence on profitability – but defining and understanding how they interact with each other can be difficult. L.E.K. has developed a Dynamic Performance Management tool which can help businesses to address this problem and improve profitability by more than 30%.

Volume XVII, Issue 34 | October 20, 2015 | By: Marcelo do Ó

Recent change in Brazil’s foreign investment law has opened the door for foreign investors to infuse capital into hospitals that primarily relied on local investors. However, hospitals and investors haven’t always been great at articulating their business strategies. In this Executive Insights, L.E.K. navigates the process for creating a sound business strategy for both parties, and advises that the best strategies start in local markets. 

Volume XVII, Issue 15 | April 30, 2015 | By: Jonas Funk, Lucas Pain, Monish Rajpal

L.E.K. believes that the MedTech industry has hit an inflection point and that the continued industry shake-out will mirror the shake-out occurring among its customers (i.e., hospital systems). In the 2015 L.E.K. Strategic Hospital Priorities Study, many of the trends revealed in the 2014 study are again impacting hospital suppliers and are indeed accelerating — with vital implications for suppliers. 

2015 State of the Industry | March 1, 2015 | By: David Barrow

Executives in the MedTech industry face many critical strategic questions in 2015. To help navigate the road ahead, L.E.K. Consulting shares its views on the current state of the industry, as well as the biggest challenges and opportunities for MedTech companies.

Volume XVI, Issue 40 | November 24, 2014 | By: Vassilis Economides, Manny Picciola, Simon Horan The Four Dimensions of Strategy Activation The Strategy Activation Roadmap

Typically, organizations have adopted a traditional two-stage approach which separates a strategy’s theory from the practice of its implementation. However, this approach is not appropriate for most modern organizations and increases the cost of strategic change, while reducing its chances of success. L.E.K. partners Vassilis Economides, Manny Picciola and Simon Horan explain why the traditional two-staged approach is no longer fit for purpose, and present an alternative solution: the "strategy activation" approach.

Volume XVI, Issue 31 | September 18, 2014 | By: Michael Connerty, Nicole Mooljee Damani Most Urgent Needs by Hospital Decision Makers Mapping Operational Performance to Growth Challenges

The medical device industry can be credited with numerous examples of improving healthcare delivery and enhancing the quality of life for many patients. However, the changing healthcare environment is contributing to several growth challenges for these MedTechs. Increasingly, OEMs are focused on operational excellence to help combat shrinking growth rates and margins. In this Executive Insights, L.E.K. Managing Directors Michael Connerty and Nicole Mooljee Damani address the four largest growth challenges for MedTechs.